200 related articles for article (PubMed ID: 8133105)
1. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
Safrin S; Elbeik T; Mills J
J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
[TBL] [Abstract][Full Text] [Related]
2. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E
J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991
[TBL] [Abstract][Full Text] [Related]
3. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
Safrin S; Kemmerly S; Plotkin B; Smith T; Weissbach N; De Veranez D; Phan LD; Cohn D
J Infect Dis; 1994 Jan; 169(1):193-6. PubMed ID: 8277181
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
6. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
7. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.
Safrin S; Elbeik T; Phan L; Robinson D; Rush J; Elbaggari A; Mills J
Antimicrob Agents Chemother; 1994 Jun; 38(6):1246-50. PubMed ID: 8092821
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
Tardif KD; Jorgensen S; Langer J; Prichard M; Schlaberg R
J Clin Virol; 2014 Nov; 61(3):382-6. PubMed ID: 25204613
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment.
Ascione C; Sala A; Mazaheri-Tehrani E; Paulone S; Palmieri B; Blasi E; Cermelli C
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):72. PubMed ID: 29137671
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
13. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].
Losada I; Cañizares A; Hellín T; Martí-Belda P; Guerrero A
Enferm Infecc Microbiol Clin; 2002 Jan; 20(1):25-7. PubMed ID: 11820977
[TBL] [Abstract][Full Text] [Related]
15. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
18. Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
Arinze F; Shaver A; Raffanti S
Infection; 2017 Oct; 45(5):705-707. PubMed ID: 28508238
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx.
Nyquist AC; Rotbart HA; Cotton M; Robinson C; Weinberg A; Hayward AR; Berens RL; Levin MJ
J Pediatr; 1994 Jun; 124(6):967-71. PubMed ID: 8201488
[TBL] [Abstract][Full Text] [Related]
20. Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice.
Li YY; Minagawa H; Tanaka S; Mori R
Antiviral Res; 1995 May; 27(1-2):111-21. PubMed ID: 7486949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
